HTLV-1 structural proteins

Virus Research

Volumn 78, Issue 1-2, 2001, Pages 5-16

  Le Blanc, I ^a   Grange, M P ^a   Delamarre, L ^a   Rosenberg, A R ^a   Blot, V ^a   Pique, C ^a   Dokhelar M C ^a  

^a INSTITUT COCHIN   (France)

Author keywords

HTLV 1; Retroviruses; Structural proteins

Indexed keywords

CAPSID PROTEIN; GAG PROTEIN; HUMAN T CELL LEUKEMIA VIRUS 1 STRUCTURAL PROTEIN; MATRIX PROTEIN; MEMBRANE PROTEIN; NUCLEOCAPSID PROTEIN; PROTEIN PRECURSOR; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BIOSYNTHESIS; CONFERENCE PAPER; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MYRISTYLATION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RETROVIRUS; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; CELL MEMBRANE; DELTARETROVIRUS; GENE PRODUCTS, GAG; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

HTLV; HUMAN T-LYMPHOTROPIC VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0034886948     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(01)00278-7     Document Type: Conference Paper

References (73)

1. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection
2. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies
3. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies
4. Structure of influenza haemagglutinin at the pH of membrane fusion
5. Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data
6. Core structure of gp41 from the HIV envelope glycoprotein
7. HIV entry and its inhibition
8. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses
9. Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7
10. Identification of functional regions in the human T-cell leukemia virus type 1 SU glycoprotein
11. The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission
12. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity
13. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera
14. The assembly of the HIV-1 env glycoprotein into dimers and tetramers
15. Folding and assembly of viral membrane proteins
16. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
17. Maturation and assembly of retroviral glycoproteins
18. Oligomeric structure of a prototype retrovirus glycoprotein
19. Mutational analysis of the oligomer assembly domain in the transmembrane subunit of the Rous sarcoma virus glycoprotein
20. Retrovirus envelope domain at 1.7 Å resolution
21. A general model for the surface glycoproteins of HIV and other retroviruses
22. Recent advances and remaining problems in HIV assembly
23. Virus maturation by budding
24. Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23
25. Transport and assembly of Gag proteins into Moloney murine leukemia virus
26. Identification of gag and env gene products of human T-cell leukemia virus (HTLV)
27. Alphavirus and flavivirus glycoproteins: Structures and functions
28. Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: Evidence for involvement of cell adhesion molecules in HTLV-1 biology
29. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia virus type I and type II using synthetic peptides
30. Enveloped viruses: A common mode of membrane fusion?
31. Macromolecular interactions in the assembly of HIV and other retroviruses
32. Viral entry and receptors
33. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63
34. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein
35. Solution structure of the capsid protein from the human T-cell leukemia virus type-I
36. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle
37. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
38. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type I
39. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range
40. Multiple roles of the basic residues of HTLV-1 matrix protein in viral transmission
41. Syncytium formation by recombinant HTLV-II envelope glycoprotein
42. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
43. Characterization of ribosomal frameshifting for expression of pol gene products of human T-cell leukemia virus type I
44. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay
45. Myristylation of gag protein in human T-cell leukemia virus type-I and type-II
46. Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK
47. Structure and expression of the human T-cell leukemia virus type 1 envelope protein
48. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins
49. Human T-cell leukemia virus type I envelope protein maturation process: Requirements for syncytium formation
50. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: A basis for envelope conservation?
51. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
52. Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication
53. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence
54. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle
55. Early assembly step of a retroviral envelope glycoprotein: Analysis using a dominant negative assay
56. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events
57. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides
58. 71-Kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1
59. Molecular events in the assembly of retrovirus particles
60. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
61. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding
62. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system
63. Synthesis, assembly and processing of viral proteins
64. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization
65. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization
66. gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains
67. Cell adhesion molecules in HTLV-I infection
68. A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene
69. Atomic structure of the ectodomain from HIV-1 gp41
70. Form, function, and use of retroviral Gag proteins
71. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
72. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
73. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids